Agendia (Netherlands)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 47 papers

  • Research Article

Abstract PS4-09-09: Distinct Immune and Metabolic profiles in Latin American breast cancer patients with obesity enrolled in FLEX

  • Feb 17, 2026
  • Clinical Cancer Research
  • M Mazo Canola +22
  • Research Article

PS5-09-19: Flex: from genomic profiling to real-world insights in 30,000 patients with early-stage breast cancer

  • Feb 17, 2026
  • Clinical Cancer Research
  • L P Gold +15
  • Open Access
  • Research Article

70P The impact of the 80-gene signature on pCR and chemotherapy treatment decisions in early-stage breast cancer: A FLEX analysis

  • May 01, 2025
  • ESMO Open
  • A.m Brufsky +6
  • Research Article

Abstract PO1-28-01: MammaPrint and BluePrint identify racial disparities among women with HR+HER2- early-stage breast cancer

  • May 02, 2024
  • Cancer Research
  • Sonya Reid +7
  • Research Article

Abstract PO4-02-03: Distribution of MammaPrint, BluePrint, and Response Predictive Subtypes based on ImPrint and Reprint in ER+/HER2- Invasive Lobular Carcinoma – A FLEX sub study

  • May 02, 2024
  • Cancer Research
  • Rita Mukhtar +18
  • Open Access
  • Research Article
  • Citations3

Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort.

  • Sep 01, 2023
  • JCO Precision Oncology
  • Tessa G Steenbruggen +13
  • Open Access
  • Preprint Article

Data from Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort

  • Mar 31, 2023
  • Ben S Wittner +11
  • Abstract
  • Citations1

239 (PB-063) Poster - An expanded 29-gene HER2 signature robustly identifies genomic HER2-Type early-stage breast tumors

  • Nov 01, 2022
  • European Journal of Cancer
  • A Ellappalayam +6
  • Research Article

Investigation of a genomic signature for transcription factor MAF gene amplification and lack of bisphosphonate benefit in early breast cancer.

  • Jun 01, 2022
  • Journal of Clinical Oncology
  • Azadeh Nasrazadani +7
  • Research Article
  • Citations3

Molecular profiles of genomically high risk ER+ HER2- breast cancer tumors classified as functionally basal or luminal B by the 80-gene signature.

  • May 20, 2021
  • Journal of Clinical Oncology
  • Joyce O'shaughnessy +14
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.